# Xiaoyan Bai

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/xiaoyan-bai/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,742 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 22 |
| i10-index | 35 |
| Last Known Institution | Dalian Medical University |
| OpenAlex ID | https://openalex.org/A5101737960 |
| ORCID iD | 0000-0002-3238-9490 |
| Works | 93 |

## Researcher papers

- [A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer](https://scholariq.org/papers/a-comprehensive-review-of-uncommon-egfr-mutations-in-patients-with-non-small/)
- [A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations](https://scholariq.org/papers/a-phase-iii-randomised-controlled-trial-of-erlotinib-vs-gefitinib-in-advanced/)
- [Long Noncoding RNA LINC01619 Regulates MicroRNA-27a/Forkhead Box Protein O1 and Endoplasmic Reticulum Stress-Mediated Podocyte Injury in Diabetic Nephropathy](https://scholariq.org/papers/long-noncoding-rna-linc01619-regulates-microrna-27a-forkhead-box-protein-o1-and/)
- [EZH2 promotes tumor progression via regulating VEGF-A/AKT signaling in non-small cell lung cancer](https://scholariq.org/papers/ezh2-promotes-tumor-progression-via-regulating-vegf-a-akt-signaling-in-non-small/)
- [MicroRNA-27a promotes podocyte injury via PPARγ-mediated β-catenin activation in diabetic nephropathy](https://scholariq.org/papers/microrna-27a-promotes-podocyte-injury-via-ppar-mediated-catenin-activation-in/)
- [MicroRNA-130b improves renal tubulointerstitial fibrosis via repression of Snail-induced epithelial-mesenchymal transition in diabetic nephropathy](https://scholariq.org/papers/microrna-130b-improves-renal-tubulointerstitial-fibrosis-via-repression-of-snail/)
- [Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome](https://scholariq.org/papers/aldehyde-dehydrogenase-1a1-possesses-stem-like-properties-and-predicts-lung/)
- [MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy](https://scholariq.org/papers/microrna-27a-promotes-renal-tubulointerstitial-fibrosis-via-suppressing-ppar/)
- [Advanced Oxidation Protein Products Promote Lipotoxicity and Tubulointerstitial Fibrosis <i>via</i> CD36/β-Catenin Pathway in Diabetic Nephropathy](https://scholariq.org/papers/advanced-oxidation-protein-products-promote-lipotoxicity-and-tubulointerstitial/)
- [WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy](https://scholariq.org/papers/wt1-ameliorates-podocyte-injury-via-repression-of-ezh2-catenin-pathway-in/)
- [Effectiveness and safety of finerenone in membranous nephropathy patients: a retrospective, real‑world study](https://scholariq.org/papers/effectiveness-and-safety-of-finerenone-in-membranous-nephropathy-patients-a/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Researcher university

- [Dalian Medical University](https://scholariq.org/institutions/dalian-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.